285 related articles for article (PubMed ID: 11374135)
1. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis.
de Gómez Dumm NT; Giammona AM; Touceda LA; Raimondi C
Medicina (B Aires); 2001; 61(2):142-6. PubMed ID: 11374135
[TBL] [Abstract][Full Text] [Related]
2. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.
Westhuyzen J; Saltissi D; Stanbury V
Ann Clin Lab Sci; 2003; 33(1):3-10. PubMed ID: 12661892
[TBL] [Abstract][Full Text] [Related]
5. [Antioxidants and malondialdehyde during hemodialysis with cellulose diacetate and polysulfone membranes].
Eiselt J; Racek J; Holecek V; Krejcová I; Opatrný K
Cas Lek Cesk; 1996 Nov; 135(21):691-4. PubMed ID: 8998818
[TBL] [Abstract][Full Text] [Related]
6. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients.
An WS; Kim SE; Kim KH; Lee S; Park Y; Kim HJ; Vaziri ND
J Ren Nutr; 2009 Jul; 19(4):267-74. PubMed ID: 19539181
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemia in patients with chronic renal failure and in renal transplant patients.
Shah B; Nair S; Sirsat RA; Ashavaid TF; Nair KG
J Postgrad Med; 1994; 40(2):57-60. PubMed ID: 8737552
[TBL] [Abstract][Full Text] [Related]
8. Incidence of gallstones in chronic renal failure patients undergoing hemodialysis: experience of a center in Turkey.
Altiparmak MR; Pamuk ON; Pamuk GE; Celik AF; Apaydin S; Cebi D; Mihmanli I; Erek E
Am J Gastroenterol; 2003 Apr; 98(4):813-20. PubMed ID: 12738461
[TBL] [Abstract][Full Text] [Related]
9. Changes in conjugated linoleic acid and palmitoleic acid are correlated to retinol levels in chronic renal failure in both hemodialysis and conservative treatment patients.
Lucchi L; Banni S; Iannone A; Melis MP; Carta G; Murru E; Cordeddu L; Stipo L; Uggeri S; Gatti V; Malaguti V; Albertazzi A
Artif Organs; 2005 May; 29(5):413-8. PubMed ID: 15854218
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
11. Effective anticoagulation by a low molecular weight heparin (Fragmin) in hemodialysis with a highly permeable polysulfone membrane.
Ljungberg B; Jacobson SH; Lins LE; Pejler G
Clin Nephrol; 1992 Aug; 38(2):97-100. PubMed ID: 1325310
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
[TBL] [Abstract][Full Text] [Related]
13. Effect of hemodialysis on the content of fatty acids in monolayers of erythrocyte membranes in patients with chronic renal failure.
Dolegowska B; Kwiatkowska E; Wesolowska T; Bober J; Chlubek D; Ciechanowski K
Ren Fail; 2007; 29(4):447-52. PubMed ID: 17497467
[TBL] [Abstract][Full Text] [Related]
14. [The effect of heparin on the lipid level during hemodialysis].
Nikolaeva NP; Siniukhin VN; Khokhlov AP; Iarmolinskiĭ IS; Stetsiuk EA
Urol Nefrol (Mosk); 1990; (5):31-3. PubMed ID: 2264204
[TBL] [Abstract][Full Text] [Related]
15. [Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients].
Tanaka H; Nishikawa O; Yukawa S; Yoshimoto M; Nishide I
Nihon Jinzo Gakkai Shi; 1999 Jan; 41(1):1-7. PubMed ID: 10077981
[TBL] [Abstract][Full Text] [Related]
16. Disordered breathing patterns during bicarbonate hemodialysis in COPD. Effect of cuprophane versus polysulfone membranes.
Navarro J; Serrano C; Donna E; Perez GO
ASAIO J; 1992; 38(4):811-4. PubMed ID: 1450477
[TBL] [Abstract][Full Text] [Related]
17. Cell membrane lipid composition in CAPD patients.
Lupo A; Bernich P; Fabris A; Zanni P; Trevisan MT; Ferrari S; Bassi A; Girelli D; Olivieri O; Maschio G
Adv Perit Dial; 1990; 6():230-2. PubMed ID: 1982814
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A
Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte membrane, plasma and atherosclerotic plaque lipid pattern in coronary heart disease.
Lausada NR; Boullón S; Boullón F; Tacconi de Gómez Dumm IN
Medicina (B Aires); 2007; 67(5):451-7. PubMed ID: 18051228
[TBL] [Abstract][Full Text] [Related]
20. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
